“…3) similarly to monomeric RNase A. Therefore, an improved interaction of the oligomers with the polyanionic cell surface followed by an efficient endocytosis was proposed for the nonetheless observed cytotoxicity (Libonati 2004). Like ?S-RNase, however, these artificial oligomers can dissociate which leads to the loss of their cytotoxic activity.…”
Section: Bs-rnase and Oligomeric Rnase Amentioning
confidence: 98%
“…Artificial oligomerization of RNase A molecules as the consequence of an intermolecular exchange of their N-and/or C-termini ('domain swapping') results in higher-order, linear or cyclic multimers, which display antitumor and aspermatogenic but no embryotoxic activity (Libonati 2004). Analogously to BS-RNase one would expect that a disturbance of the RNase-RI interaction is responsible for the acquired cytotoxicity.…”
Section: Bs-rnase and Oligomeric Rnase Amentioning
confidence: 98%
“…Even though tandemization obviously did not result in an improved RI evasion in vitro, the constructs showed pronounced cytotoxicity (Leich et al 2006). An improved endocytosis as proposed for domain swapped RNase A oligomers (Libonati 2004) might be the reason for the increased cytotoxicity.…”
By reason of their cytotoxicity, ribonucleases (RNases) are potential anti-tumor drugs. Particularly members from the RNase A and RNase T1 superfamilies have shown promising results. Among these enzymes, Onconase, an RNase from the Northern Leopard frog, is furthest along in clinical trials. A general model for the mechanism of the cytotoxic action of RNases includes the interaction of the enzyme with the cellular membrane, internalization, translocation to the cytosol, and degradation of ribonucleic acid. The interplay of these processes as well as the role of the thermodynamic and proteolytic stability, the catalytic activity, and the capability of the RNase to evade the intracellular RNase inhibitor has not yet been fully elucidated. This paper discusses the various approaches to exploit RNases as cytotoxic agents.
“…3) similarly to monomeric RNase A. Therefore, an improved interaction of the oligomers with the polyanionic cell surface followed by an efficient endocytosis was proposed for the nonetheless observed cytotoxicity (Libonati 2004). Like ?S-RNase, however, these artificial oligomers can dissociate which leads to the loss of their cytotoxic activity.…”
Section: Bs-rnase and Oligomeric Rnase Amentioning
confidence: 98%
“…Artificial oligomerization of RNase A molecules as the consequence of an intermolecular exchange of their N-and/or C-termini ('domain swapping') results in higher-order, linear or cyclic multimers, which display antitumor and aspermatogenic but no embryotoxic activity (Libonati 2004). Analogously to BS-RNase one would expect that a disturbance of the RNase-RI interaction is responsible for the acquired cytotoxicity.…”
Section: Bs-rnase and Oligomeric Rnase Amentioning
confidence: 98%
“…Even though tandemization obviously did not result in an improved RI evasion in vitro, the constructs showed pronounced cytotoxicity (Leich et al 2006). An improved endocytosis as proposed for domain swapped RNase A oligomers (Libonati 2004) might be the reason for the increased cytotoxicity.…”
By reason of their cytotoxicity, ribonucleases (RNases) are potential anti-tumor drugs. Particularly members from the RNase A and RNase T1 superfamilies have shown promising results. Among these enzymes, Onconase, an RNase from the Northern Leopard frog, is furthest along in clinical trials. A general model for the mechanism of the cytotoxic action of RNases includes the interaction of the enzyme with the cellular membrane, internalization, translocation to the cytosol, and degradation of ribonucleic acid. The interplay of these processes as well as the role of the thermodynamic and proteolytic stability, the catalytic activity, and the capability of the RNase to evade the intracellular RNase inhibitor has not yet been fully elucidated. This paper discusses the various approaches to exploit RNases as cytotoxic agents.
“…7,8 Thus, despite some notable exceptions, such as that provided by a human-frog ribonuclease chimera, 9 RI action and cytotoxicity appear to be strongly anticorrelated. 6,10 In keeping with this indication, the production of aggregated forms of ribonucleases that are not amenable to RI binding for steric hindrance [11][12][13][14] may provide a way to produce proteins possessing enhanced cytotoxic effects. In this scenario, bovine seminal ribonuclease (BS-RNase) occupies a special position (Fig.…”
Section: Introductionmentioning
confidence: 93%
“…25 Surprisingly, these dimers display a detectable cytotoxic activity, although significantly smaller in comparison to BS-RNase. [11][12][13] However, it should be pointed out that the two units of NDRNaseA molecule 23,26 are not related by a 2-fold symmetry. Therefore, while the binding of one chain in the RI binding site can easily occur, the binding of the second subunit gives rise to severe interpenetration of the partner chain on the inhibitor molecule.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.